Description:Title:

Advancing Medical Diagnostics: Utilizing Adversarial GANs for Enhanced Imaging and Precision Medicine

Field of the Invention

[0001] The present invention is related to the computer science and machine learning field.

Background

[0002] Medical imaging technologies, such as MRI, CT scans, and X-rays, are crucial for diagnosing and monitoring various health conditions. Traditional imaging techniques have limitations in terms of resolution, clarity, and noise, which can affect diagnostic accuracy. Enhancing these images can significantly improve the ability to detect and treat diseases early.
[0003] GANs are a type of artificial intelligence model introduced by Ian Goodfellow in 2014. They consist of two neural networks, the generator and the discriminator, which work in tandem to produce high-quality, realistic data. In medical imaging, GANs can be used to generate enhanced images by learning from existing medical data, thereby improving image quality and reducing noise.
[0004] By training on large datasets of medical images, GANs can learn to generate more detailed and higher resolution images. This capability is particularly useful in situations where high-quality images are required for accurate diagnosis but are difficult to obtain due to technical or practical limitations. GANs can help in enhancing low-quality images, filling in missing data, and providing clearer visualizations.
[0005] Precision medicine aims to tailor medical treatment to individual characteristics of each patient, often based on genetic, environmental, and lifestyle factors. Enhanced imaging through GANs can play a critical role in precision medicine by providing more accurate and detailed diagnostic information. This can lead to more precise treatment plans, better monitoring of disease progression, and ultimately, improved patient outcomes.
[0006] All publications herein are incorporated by reference to the same extent as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Where a definition or use of a term in an incorporated reference is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.
[0007] In some embodiments, the numbers expressing quantities of ingredients, properties such as concentration, reaction conditions, and so forth, used to describe and claim certain embodiments of the invention are to be understood as being modified in some instances by the term “about.” Accordingly, in some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The numerical values presented in some embodiments of the invention may contain certain errors necessarily resulting from the standard deviation found in their respective testing measurements.
[0008] As used in the description herein and throughout the claims that follow, the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise.
[0009] The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non- claimed element essential to the practice of the invention.
[0010] Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member can be referred to and claimed individually or in any combination with other members of the group or other elements found herein. One or more members of a group can be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.

Objects of the Invention

[0011] One of the main objectives is to enhance the quality and resolution of medical images, thereby improving the accuracy of diagnoses. By reducing noise and filling in missing data, GANs can help medical professionals detect diseases earlier and more accurately, which is crucial for effective treatment and patient outcomes.
[0012] Another objective is to support precision medicine by providing more detailed and individualized diagnostic information. Enhanced imaging can help in tailoring treatment plans to the specific needs of each patient based on precise and comprehensive imaging data, leading to more effective and personalized healthcare.

Drawings

Figure 1

Brief Description of the Drawing

[0013] The figure 1 represents working model in the present invention with its prototype.

Detailed Description:

[0014] In figure 1, showing the input parameter; which is to be processed by the system 100.

[0015] Gather a large dataset of medical images from various sources, such as hospitals, research institutions, and publicly available medical databases. Preprocess the data to ensure consistency, which may include resizing images, normalizing pixel values, and labeling images with relevant diagnostic information.
[0016] Choose an appropriate GAN architecture, such as a Deep Convolutional GAN (DCGAN) or a Super-Resolution GAN (SRGAN), depending on the specific enhancement needs. Design the generator and discriminator networks to suit the medical imaging requirements, focusing on factors like resolution, image size, and the type of medical imaging modality.
[0017] Split the dataset into training, validation, and test sets to ensure the model can generalize well to new data. Train the GAN using the training set, iteratively improving the generator’s ability to create realistic enhanced images and the discriminator’s ability to distinguish between real and generated images. Monitor training progress using validation data, adjusting hyperparameters as needed to optimize performance.
[0018] Evaluate the GAN’s performance on the test set using metrics such as Peak Signal-to-Noise Ratio (PSNR), Structural Similarity Index (SSIM), and diagnostic accuracy improvements. Conduct qualitative assessments with medical professionals to ensure the enhanced images are clinically useful and of high quality.
[0019] Develop software tools or integrate the GAN model into existing medical imaging systems, ensuring it can be easily used by healthcare providers. Train medical staff on how to use the enhanced imaging tools, emphasizing the benefits and any limitations of the technology.
[0020] Conduct clinical trials to test the effectiveness of the GAN-enhanced imaging in real-world diagnostic scenarios. Collect feedback from medical professionals on the usability and accuracy of the enhanced images, using this feedback to further refine the model.
[0021] Set up a monitoring system to continually assess the performance of the GAN-enhanced imaging in clinical practice. Update the model periodically with new data and improvements in GAN technology, ensuring it remains state-of-the-art and continues to provide value in medical diagnostics.
[0022] In an aspect, any or a combination of machine learning mechanisms such as decision tree learning, Bayesian network, deep learning, random forest, supervised vector machines, reinforcement learning, prediction models, Statistical Algorithms, Classification, Logistic Regression, Support Vector Machines, Linear Discriminant Analysis, K- Nearest Neighbours, Decision Trees, Random Forests, Regression, Linear Regression, Support Vector Regression, Logistic Regression, Ridge Regression, Partial Least-Squares Regression, Non-Linear Regression, Clustering, Hierarchical Clustering – Agglomerative, Hierarchical Clustering
– Divisive, K-Means Clustering, K-Nearest Neighbours Clustering, EM (Expectation Maximization) Clustering, Principal Components Analysis Clustering (PCA), Dimensionality Reduction, Non-Negative Matrix Factorization (NMF), Kernel PCA, Linear Discriminant Analysis (LDA), Generalized Discriminant Analysis (kernel trick again), Ensemble Algorithms, Deep Learning, Reinforcement Learning, AutoML (Bonus) and the like can be employed to learn sensor/hardware components.
[0023] The term “non-transitory storage device” or “storage” or “memory,” as used herein relates to a random access memory, read only memory and variants thereof, in which a computer can store data or software for any duration.
[0024] It should be apparent to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the spirit of the appended claims. Moreover, in interpreting both the specification and the claims, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as referring to elements, components, or steps in a non-
exclusive manner, indicating that the referenced elements, components, or
steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced. Where the specification claims refer to at least one of something selected from the group consisting of A, B, C …. and N, the text should be interpreted as requiring only one element from the group, not A plus N, or B plus N, etc.
, Claims:1.Enhanced Diagnostic Accuracy: Utilizing Adversarial GANs can significantly improve the quality and resolution of medical images, leading to more accurate and earlier diagnosis of diseases. This enhancement can reduce the likelihood of misdiagnosis and improve patient outcomes by enabling timely and precise medical interventions.
2.Reduction in Imaging Artifacts and Noise: GANs are capable of reducing artifacts and noise present in traditional medical imaging techniques. This leads to clearer and more detailed images, which are crucial for identifying subtle pathological changes that might be missed in noisier or lower-quality images.
3.Support for Personalized Medicine: The enhanced imaging provided by GANs can offer more detailed insights into individual patient conditions, facilitating the development of personalized treatment plans. This aligns with the goals of precision medicine, where treatments are tailored to the specific genetic, environmental, and lifestyle factors of each patient, ultimately improving treatment efficacy and patient care.